Cancel anytime
Everest Consolidator Acquisition Corp (MNTN)MNTN
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: MNTN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 12.18% | Upturn Advisory Performance 4 | Avg. Invested days: 132 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 12.18% | Avg. Invested days: 132 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 84.09M USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -0.31 |
Volume (30-day avg) 8528 | Beta 0.01 |
52 Weeks Range 10.82 - 12.18 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 84.09M USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -0.31 | Volume (30-day avg) 8528 | Beta 0.01 |
52 Weeks Range 10.82 - 12.18 | Updated Date 11/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -4.01% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 137850853 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -21.56 |
Shares Outstanding 7392110 | Shares Floating 6133449 |
Percent Insiders - | Percent Institutions 89.9 |
Trailing PE - | Forward PE - | Enterprise Value 137850853 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA -21.56 | Shares Outstanding 7392110 | Shares Floating 6133449 |
Percent Insiders - | Percent Institutions 89.9 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Everest Consolidator Acquisition Corp. (EAC) - Comprehensive Overview
Company Profile:
Detailed history and background:
Everest Consolidator Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in November 2021 with no specific business plan or existing operations.
Core business areas:
Everest Consolidator Acquisition Corp. is focused on identifying and acquiring businesses within the healthcare sector. They specifically target companies operating in the areas of healthcare services, technology, pharmaceuticals, life sciences, or medical devices.
Leadership team and corporate structure:
- Chairman & CEO: Jeffrey A. Leer
- President & COO: Matthew D. Sager
- Board of Directors: Composed of experienced professionals from diverse backgrounds within the healthcare industry.
Top Products and Market Share:
As a SPAC with no active business, Everest Consolidator Acquisition Corp. does not yet have any products or market share. They aim to acquire a target company that will become their primary offering upon business combination.
Total Addressable Market:
The global healthcare market is expected to reach a value of approximately $12,278.37 billion by 2028 with a CAGR of 9.7%. Everest Consolidator Acquisition Corp. specifically targets the US healthcare market, estimated at $4.3 trillion in 2023 and growing.
Financial Performance:
As a pre-revenue company, Everest Consolidator Acquisition Corp. currently has no revenue, net income, or earnings per share. Their financial reports primarily reflect administrative and offering expenses.
Dividends and Shareholder Returns:
Being a pre-revenue company, Everest Consolidator Acquisition Corp. has not paid any dividends and has no track record for shareholder returns.
Growth Trajectory:
Given their early stage and lack of established operations, evaluating Everest Consolidator Acquisition Corp.'s historical growth is not applicable. Their future growth will depend entirely on the target company they acquire and its subsequent performance.
Market Dynamics:
The healthcare industry is characterized by constant innovation, technological advancements, and changing regulatory landscapes. Everest Consolidator Acquisition Corp.'s ability to adapt to these dynamics will be crucial for their success.
Competitors:
Key competitors in the healthcare M&A space include:
- Healthcare Merger Corp. (HMCR)
- MedTech Acquisition Corp. (MTAC)
- Biofrontera Inc. (BFRI)
These competitors differ in their target market segments and acquisition strategies.
Recent Acquisitions:
As a company formed in November 2021, Everest Consolidator Acquisition Corp. has not yet announced any acquisitions.
Potential Challenges and Opportunities:
Challenges:
- Identifying and acquiring a suitable target company within their timeframe.
- Integrating the acquired company seamlessly and efficiently.
- Adapting to rapid changes in the healthcare sector.
- Competing with other SPACs and investors for attractive targets.
Opportunities:
- Capitalizing on the fragmented healthcare market through consolidation.
- Leveraging technological advancements to improve healthcare services.
- Expanding into new markets and service areas.
- Building a diverse portfolio of healthcare assets with strong growth potential.
AI-Based Fundamental Rating:
Rating: 6/10
Everest Consolidator Acquisition Corp. receives a moderate rating of 6/10 based on their current position as a pre-revenue SPAC. While they demonstrate strong leadership and have a clear focus on the healthcare sector, their future success relies heavily on identifying and completing a successful business combination with a viable target company.
Sources and Disclaimers:
Sources:
- Everest Consolidator Acquisition Corp. (EAC) SEC Filings: https://www.sec.gov/edgar/search/#/company?cik=1865486
- Everest Consolidator Acquisition Corp. Investor Relations: https://www.everestconsolidator.com/
- Statista - Global Healthcare Market Size: https://www.statista.com/statistics/971980/global-healthcare-market-size/
- Grand View Research - US Healthcare Market Size: https://www.grandviewresearch.com/industry-analysis/healthcare-market
Disclaimer:
This information is presented for informational purposes only and is not intended as financial advice.
Conclusion:
Everest Consolidator Acquisition Corp. offers investors an opportunity to participate in the growth potential of the healthcare sector through acquisition strategies. However, its early stage and dependence on future acquisitions necessitate careful due diligence before investment.
I trust this comprehensive overview provides valuable insights on Everest Consolidator Acquisition Corp.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Everest Consolidator Acquisition Corp
Exchange | NYSE | Headquaters | Newport Beach, CA, United States |
IPO Launch date | 2022-01-14 | CEO | - |
Sector | Financial Services | Website | https://belayoneverest.com |
Industry | Shell Companies | Full time employees | - |
Headquaters | Newport Beach, CA, United States | ||
CEO | - | ||
Website | https://belayoneverest.com | ||
Website | https://belayoneverest.com | ||
Full time employees | - |
Everest Consolidator Acquisition Corporation does not have significant operations. The company intends to a effect merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on identifying businesses in the financial services sector. The company was incorporated in 2021 and is based in Newport Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.